Nilda Mesa - 08 Jul 2022 Form 4/A - Amendment Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role: Director
Signature: /s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol: UTHR
Transactions as of: 08 Jul 2022
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 11 Jul 2022, 16:30:22 UTC
Date Of Original Report: 08 Jul 2022
Previous filing: 08 Jul 2022
Next filing: 30 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	UTHR	Common Stock	Options Exercise	$0	+1,080	+16%	$0.000000	7,720	08 Jul 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	UTHR	Restricted Stock Unit	Options Exercise	$0	-1,080	-100%	$0.000000^*	0	08 Jul 2022	Common Stock	1,080	$0.000000	Direct	F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares received upon vesting of restricted stock units on July 8, 2022. Restricted stock units converted on a one-for-one basis into shares of common stock.
F2	Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
F3	This amendment corrects an error in the original filing, which incorrectly listed these restricted stock units as "Acquired" instead of "Disposed of".
F4	Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.